AUPH (STOCKS)
Aurinia Pharmaceuticals Inc
$14.870000
+0.310000 (+2.13%)
Prev close: $14.560000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Peter S. Greenleaf
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,928.90M
- Employees
- 300
- P/E (TTM)
- 25.95
- P/B (TTM)
- 5.25
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.23 | $0.16 | +0.0668 | +40.93% |
|
Jun 2025 (Q2)
|
$0.16 | $0.15 | +0.0104 | +6.95% |
|
Mar 2025 (Q1)
|
$0.16 | $0.10 | +0.0580 | +56.86% |
|
Dec 2024 (Q4)
|
$0.01 | $-0.02 | +0.0263 | +161.35% |
Financial Statements
| Assets | $527.53M |
| Current Assets | $438.74M |
| Inventory | $44.79M |
| Other Current Assets | $393.94M |
| Noncurrent Assets | $88.79M |
| Fixed Assets | $2.27M |
| Other Non-current Assets | $86.53M |
| Liabilities | $161.76M |
| Current Liabilities | $76.22M |
| Accounts Payable | $2.21M |
| Wages | $9.76M |
| Other Current Liabilities | $64.24M |
| Noncurrent Liabilities | $85.54M |
| Equity | $365.77M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $365.77M |
| Liabilities And Equity | $527.53M |